Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.370
+0.050 (2.16%)
At close: May 13, 2025, 4:00 PM
2.260
-0.110 (-4.64%)
Pre-market: May 14, 2025, 8:00 AM EDT
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $68.40 million as of May 14, 2025. Its market cap has decreased by -46.73% in one year.
Market Cap
68.40M
Enterprise Value
-18.44M
1-Year Change
-46.73%
Ranking
Category
Stock Price
$2.37
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $68.40M, an increase of 635.52%. That is a compound annual growth rate of 24.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 68.40M | -16.69% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |